Literature DB >> 16333416

Caspofungin: the first agent available in the echinocandin class of antifungals.

Joseph Rybowicz1, Cheryle Gurk-Turner.   

Abstract

Entities:  

Year:  2002        PMID： 16333416      PMCID： PMC1276345          DOI： 10.1080/08998280.2002.11927822

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  13 in total

1.  In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species.

Authors:  F Barchiesi; A M Schimizzi; A W Fothergill; G Scalise; M G Rinaldi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-04       Impact factor: 3.267

2.  Treatment of murine disseminated candidiasis with L-743,872.

Authors:  J R Graybill; L K Najvar; M F Luther; A W Fothergill
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors.

Authors:  J Onishi; M Meinz; J Thompson; J Curotto; S Dreikorn; M Rosenbach; C Douglas; G Abruzzo; A Flattery; L Kong; A Cabello; F Vicente; F Pelaez; M T Diez; I Martin; G Bills; R Giacobbe; A Dombrowski; R Schwartz; S Morris; G Harris; A Tsipouras; K Wilson; M B Kurtz
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species.

Authors:  J A Vazquez; M Lynch; D Boikov; J D Sobel
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.

Authors:  T V Krishnarao; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

6.  In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872).

Authors:  K Bartizal; C J Gill; G K Abruzzo; A M Flattery; L Kong; P M Scott; J G Smith; C E Leighton; A Bouffard; J F Dropinski; J Balkovec
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

7.  Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

8.  Quality control limits for broth microdilution susceptibility tests of ten antifungal agents.

Authors:  A L Barry; M A Pfaller; S D Brown; A Espinel-Ingroff; M A Ghannoum; C Knapp; R P Rennie; J H Rex; M G Rinaldi
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

9.  Treatment of histoplasmosis with MK-991 (L-743,872).

Authors:  J R Graybill; L K Najvar; E M Montalbo; F J Barchiesi; M F Luther; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

10.  Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii.

Authors:  M A Powles; P Liberator; J Anderson; Y Karkhanis; J F Dropinski; F A Bouffard; J M Balkovec; H Fujioka; M Aikawa; D McFadden; D Schmatz
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191
View more
  2 in total

1.  Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents.

Authors:  Christopher F Hoehamer; Edwin D Cummings; George M Hilliard; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

2.  Heterogeneity in the transcriptional response of the human pathogen Aspergillus fumigatus to the antifungal agent caspofungin.

Authors:  Ana Cristina Colabardini; Fang Wang; Zhiqiang Dong; Lakhansing Pardeshi; Marina Campos Rocha; Jonas Henrique Costa; Thaila Fernanda Dos Reis; Alec Brown; Qais Z Jaber; Micha Fridman; Taicia Fill; Antonis Rokas; Iran Malavazi; Koon Ho Wong; Gustavo Henrique Goldman
Journal:  Genetics       Date:  2022-01-04       Impact factor: 4.402
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.